2-Furancarboxamide,N-[2-(1,2,6,7,8,9-hexahydro-2-oxopyrido[2,3-b]indolizin-10-yl)ethyl]- (334781-07-6)

Identification
Name:	2-Furancarboxamide,N-[2-(1,2,6,7,8,9-hexahydro-2-oxopyrido[2,3-b]indolizin-10-yl)ethyl]-
CAS:	334781-07-6
Molecular Formula:	C₁₈H₁₉N₃O₃
Molecular Structure:
Properties
Safety Data

Other Product

Spiro[3H-indole-3,1'(5'H)-indolizin]-2(1H)-one,6'-ethyl-2',3',6',7',8',8'a-hexahydro-7'-(2-hydroxyethyl)-, (1'S,6'R,7'R,8'aS)-
Acetamide,N-[2-(6-bromo-8,11,12,13-tetrahydro-12-oxopyrido[4,3,2-mn][1,4]thiazino[3,2-b]acridin-9-yl)ethyl]-
Spiro[3H-indole-3,1'(5'H)-indolizin]-2(1H)-one,6'-ethyl-2',3',6',7',8',8'a-hexahydro-7'-(2-hydroxyethyl)-, (1'R,6'R,7'R,8'aS)-
Benzamide,N-[3-(2-amino-7,8-dihydro-8-methyl-7-oxopyrido[2,3-d]pyrimidin-6-yl)-4-methylphenyl]-3-(trifluoromethyl)-
N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide
Spiro[3H-indole-3,1'(5'H)-indolizin]-2(1H)-one,6'-ethenyl-2',3',6',7',8',8'a-hexahydro-6- hydroxy-7-[(2R)-1-methyl-2-pyrrolidinyl]- 7'-[[(1S)-2,3,4,9-tetrahydro-2-methyl-1Hpyrido[ 3,4-b]indol-1-yl]methyl]-,(1'S,6'R,7'S,- 8'aS)-
Spiro[3H-indole-3,1'(5'H)-indolizin]-2(1H)-one,6'-ethenyl-2',3',6',7',8',8'a-hexahydro-6- hydroxy-7-[(2R)-1-methyl-2-pyrrolidinyl]- 7'-[[(1S)-2,3,4,9-tetrahydro-2-methyl-1Hpyrido[ 3,4-b]indol-1-yl]methyl]-,(1'R,6'R,7'S,- 8'aS)-
Benzamide,N-[4-chloro-3-[7,8-dihydro-2-[[3-(1-hydroxyethyl)phenyl]amino]-8-methyl-7-oxopyrido[2,3-d]pyrimidin-6-yl]phenyl]-N-methyl-3-(trifluoromethyl)-
2-Pyrrolidinemethanol,1-[(4,6-dihydro-6-oxo-7-phenylthieno[2,3-a]indolizin-9-yl)carbonyl]-, (R)-
Benzamide,N-[4-chloro-3-[7,8-dihydro-2-[[3-(1-hydroxyethyl)phenyl]amino]-8-methyl-7-oxopyrido[2,3-d]pyrimidin-6-yl]phenyl]-3-(trifluoromethyl)-
Spiro[3H-indole-3,1'(5'H)-indolizin]-2(1H)-one,6'-ethenyl-2',3',6',7',8',8'a-hexahydro-6-hydroxy-7'-[[(1S)-2,3,4,9-tetrahydro-2-methyl-1H-pyrido[3,4-b]indol-1-yl]methyl]-,(1'R,6'R,7'R,8'aS)-
Isoquinolinium,2-methyl-1-(3-methyl-1-phenyl-1H-pyrazolo[3,4-b]indolizin-9-yl)-, iodide
L-Glutamic acid,N-[4-[2-[(6R)-2-amino-3,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]-
(S)-4-[2-(2-Amino-1,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl)ethyl]benzonitrile
(1’S,3’S,8a’R)-3’-((Z)-2-iodovinyl)-3’,5’,6’,7’,8’,8a’-hexahydro-2’H,5H-spiro[furan-2,1’-indolizin]-5-one
L-Glutamic acid,N-[4-[2-[(6R)-2-amino-3,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]-,sodium salt (1:2)
(4-chlorophenyl)(9-ethylfuro[2,3-b]indolizin-2-yl)methanone
Acetamide,N-[2-(8,11,12,13-tetrahydro-12-oxopyrido[4,3,2-mn][1,4]thiazino[3,2-b]acridin-9-yl)ethyl]-
Acetamide,N-[2-(6,7,8,9-tetrahydro-3-methoxypyrido[3,2-b]indolizin-5-yl)ethyl]-
3-(indolizin-2-yl)phenol